Samsung brings upgraded sleep apnoea detection to Galaxy Ring
Samsung’s upgraded sleep-apnoea screening feature is now available on Galaxy Ring in the US after FDA and South Korean regulatory approvals.
Samsung has made its upgraded Sleep Apnea feature available on the Galaxy Ring in the United States, following FDA clearance in July and approval from South Korea’s Ministry of Food and Drug Safety. Samsung describes the update as the first FDA-cleared over-the-counter sleep-apnoea risk-detection feature brought to a smart ring. 12
The feature runs through the Samsung Health Monitor app and analyses signals gathered during sleep, including blood-oxygen changes and movement. Samsung says the updated algorithm goes beyond the earlier yes-or-no style risk assessment by estimating the number of significant breathing disruptions per hour. 1
Users must record two nights of sleep within a 10-day period to receive an assessment. The feature is intended for adults aged 18 and over who have not previously been diagnosed with sleep apnoea. Samsung says the rollout also supports the Galaxy Watch9 running Wear OS 7 or later, while support for the Galaxy Watch7 and Watch8 is planned through future software updates. 1
The update matters because the Galaxy Ring is designed to be worn overnight without putting a watch on the wrist. That makes it a different route into Samsung’s sleep-health tools, although the company’s own documentation is clear about the limits: the software is intended to detect possible signs of moderate to severe sleep apnoea, not to provide a medical diagnosis. Anyone receiving a concerning result should speak to a qualified healthcare professional rather than treating the app as a replacement for clinical testing. 1
Samsung has not confirmed when the upgraded feature will reach additional countries. Availability therefore remains limited by both geography and compatible hardware, even as the company says it plans a wider expansion. 1
Our opinion
The Galaxy Ring is a sensible place for Samsung to put this feature because overnight comfort is its strongest practical argument over a smartwatch. The important distinction is that this is screening, not diagnosis: a more detailed estimate may make a conversation with a clinician more useful, but it cannot settle the medical question. Samsung’s two-night requirement keeps the feature relatively light-touch, while the lack of a confirmed wider rollout means buyers outside the US should not assume the update is already available in their market.